DNTH: Dianthus Therapeutics Inc Sotuvga nisbatan narx
Operatsion pul oqimining yetishmasligi va R&D investitsiyalariga strategik bog'liqlik Dianthus Therapeutics (DNTH) uchun ma'lum bir rivojlanish inertiyasini yuzaga keltirmoqda. Sotuvlarga nisbatan narx koeffitsiyenti ushbu konsolidatsiya bosqichlarini vizuallashtiradi, bunda joriy ko'rsatkich 1898.80 darajasida turibdi. Biznes asosi robotlashtirilgan antitelalarni skrining qilish va klinik sinovlar uchun reagentlarni tashish jarayonida qat'iy logistik nazoratga asoslangan.
Dianthus Pharma (DNTH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Dianthus Corp|DNTH - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Dianthus Pharma|DNTH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Dianthus Therapeutics|Tezkor likvidlik koeffitsiyenti dianthustx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
DNTH - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi Dianthus Therapeutics|DNTH - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Dianthus Therapeutics Inc|DNTH - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Dianthus Pharma|DNTH - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Dianthus Therapeutics|DNTH - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi dianthustx.com|DNTH - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Dianthus Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:dianthustx.com
P/S koeffitsienti biznesning bozor qiymatini uning generatsiya qilgan savdo aylanmasi bilan solishtiradi, bu esa fundamental baholashda daromadning har bir birligi uchun to'langan premiumni aniqlash imkonini beradi. P/S grafigini tahlil qilish orqali investor Dianthus Therapeutics (DNTH) kompaniyasining kapitalizatsiya barqarorligini aniqlashi mumkin, bunda oqsil sintezi shartnomalarining diversifikatsiyasi xomashyo risklarini minimallashtiradi va noyob patologiyalarni davolash uchun antitanachlar ishlab chiqish jarayonida barqaror marjalarni ta'minlaydi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX (Protagonist Corp) - Kapitalizatsiya va daromad nisbati|IMVT: P/S multiplikatori|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols) - P/S multiplikatori|P/S multiplikatori Adaptive Biotech|Narxning daromadga nisbati Celldex (CLDX)|Aurinia Corp - Kapitalizatsiya va daromad nisbati|BioCryst - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati VERA (veratx.com)|Pharvaris - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ABCL (AbCellera Biologics Inc.)|TRML (Tourmaline Corp) - Kapitalizatsiyaning daromadga nisbati|Precigen Corp (PGEN) - P/S multiplikatori|Narxning daromadga nisbati Pharming Group N.V.|nektar.com (NKTR) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati UPB (Upstream Bio)|ZBIO (Zenas Bio) - Bozor kapitallashuvining daromadga nisbati|Immunome Corp - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati GOSS (Gossamer Bio Corp.)|KalVista Pharmaceuticals - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati SEPN (septerna.com)|PVLA: P/S multiplikatori|Sotuvga nisbatan narx Savara Inc (SVRA)|Narxning daromadga nisbati Rigel Pharmaceuticals Inc|ANAB: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ATXS|P/S multiplikatori engene.com (ENGN)|Narxning daromadga nisbati RAPT Therapeutics RAPT|JBIO (Aerovate Therapeutics, Inc.) - Narxning sotuvga nisbati|Aclaris - P/S multiplikatori|Sotuvga nisbatan narx Kyverna Therapeutics, Inc|TLSA (Tiziana Life Sciences) - Kapitalizatsiyaning daromadga nisbati|cabalettabio.com (CABA) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati VTYX|THTX (Theratechnologies, Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori AVTX|Narx/daromad koeffitsiyenti Eledon Pharmaceuticals, Inc|P/S multiplikatori AGEN (Agenus)|CLYM - Kapitalizatsiyaning daromadga nisbati|ZURA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti aTyr Pharma Inc ATYR|ADAG: P/S multiplikatori|Kapitalizatsiya va daromad nisbati IMA|Narxning daromadga nisbati Shattuck Labs Inc|Kapitalizatsiya va daromad nisbati EQ (Equillium Bio)|Kapitalizatsiyaning daromadga nisbati CNTB (Connect Biopharma)|Kapitalizatsiyaning sotish hajmiga nisbati IMUX|P/S multiplikatori ATRA (Atara Bio)|Bozor kapitallashuvining daromadga nisbati IFRX|XFOR - Narxning daromadga nisbati|Narxning sotuvga nisbati ACET|CELU: P/S multiplikatori|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|BRNS (Barinthus Bio) - P/S multiplikatori|P/S multiplikatori Kezar Life Sciences Inc|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|AKTX (akaritx.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Kapitalizatsiyaning daromadga nisbati|GeoVax Labs Inc - P/S multiplikatori|EDSA - P/S multiplikatori|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Carisma Therapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Bolt Bio (BOLT) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Kapitalizatsiyaning daromadga nisbati aptevotherapeutics.com APVO|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI: Kapitalizatsiyaning daromadga nisbati|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati REVB|INDP (Indaptus Therapeutics) - P/S multiplikatori|Sotuvga nisbatan narx scinai.com SCNI|P/S multiplikatori CALI|affimed.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ALLK (Allakos)|Narx/daromad koeffitsiyenti HOOKIPA Pharma, Inc. (HOOK)|IGM Bio - P/S multiplikatori|ITOS - P/S multiplikatori|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati TCBP|Kapitalizatsiyaning daromadga nisbati THRD
